PACE-CME

Novel strategy of triple therapy with bempedoic acid, ezetimibe and statin

Novel strategy of triple therapy with bempedoic acid ezetimibe and statin
RestartResume
5' education - Apr. 8, 2021 - Prof. Stephen Nicholls, MD
  • Overview

    Prof. Stephen Nicholls discusses the results of a study that investigated the lipid-lowering effects of triple therapy with bempedoic acid, ezetimibe and statin as a new potential strategy for treating hypercholesterolemia.

  • Educational information

    This video was recorded in response to a recent publication in Atherosclerosis by prof. Stephen Nicholls and colleagues.

  • Faculty

    Prof. Stephen Nicholls is professor of Cardiology and director of MonashHeart in Melbourne, Australia.

  • Disclosures

    This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.

    Read our summary of this article

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free